Broad-spectrum vaccine via combined immunization routes triggers potent immunity to SARS-CoV-2 and its variants
Journal of Virology · 2023
DOI: 10.1128/jvi.00724-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2023. Verfasst von Man Xing und 18 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Public Health Clinical Center, Fudan University , Shanghai, China. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Vaccines, Combined. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation), MOST | National Key Research and Development Program of China (NKPs).
Abstract (Originalsprache)
Developing broad-spectrum vaccines and optimal vaccination strategies is crucial to controlling the COVID-19 pandemic. Here, we generated a chimpanzee adenoviral vector-based COVID-19 vaccine carrying broad-spectrum immunogens, modified full-length spike, and conserved T-cell epitopes of SARS-CoV-2, and assessed its immune response in mice through intramuscular (i.m.), intranasal (i.n.), or combined immunization routes (i.m. + i.n., or i.n. + i.m.). Compared to other vaccination strategies, the two combined regimens elicited higher neutralizing antibody (NAb) responses to all variants. Compared to i.n. + i.m. regimen, the i.m. + i.n. regimen stimulated a stronger secondary GC response, which is more pivotal to high-quality antibody production than the primary GC response. Moreover, the i.m. + i.n. regimen was adept at mediating systemic cellular immunity, while the i.n. + i .m. regimen tended to elicit lung tissue-resident memory T (T RM ) cell responses. Overall, the two combined regimens induced comprehensive but distinct immune responses consisting of lgA, lgG, NAbs, GC B cells, long-lived plasma cells, T RM cells, and systemic memory T cells, which conferred complete protection against BA.2 infection in hACE2 transgenic mice, and warranted further investigation as potential universal vaccination strategies. IMPORTANCE The development of broad-spectrum SARS-CoV-2 vaccines will reduce the global economic and public health stress from the COVID-19 pandemic. The use of conserved T-cell epitopes in combination with spike antigen that induce humoral and cellular immune responses simultaneously may be a promising strategy to further enhance the broad spectrum of COVID-19 vaccine candidates. Moreover, this research suggests that the combined vaccination strategies have the ability to induce both effective systemic and mucosal immunity, which may represent promising strategies for maximizing the protective efficacy of respiratory virus vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Public Health Clinical Center, Fudan University , Shanghai, China.
- Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University , Tianjin, China.
- MOE&NHC&CAMS Key Laboratory of Medical Molecular Virology, Shanghai Institute of Infections Disease and Biosecurity, Frontiers Science Center of Pathogenic Microorganisms and Infection, School of Basic Medical Sciences,…
- MOE&NHC&CAMS Key Laboratory of Medical Molecular, Frontiers Science Center of Pathogenic Microorganisms and Infection, School of Basic Medical Sciences, Shanghai Medical College, Fudan University , Shanghai, China.
- Department of Infectious Diseases, Tianjin Medical University General Hospital , Tianjin, China.
- Department of Clinical Laboratory, Tianjin Medical University General Hospital , Tianjin, China.
ORCID-Profile: Man Xing, Qiliang Cai
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation)
- MOST | National Key Research and Development Program of China (NKPs)
- Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Foundation)
Zitieren
APA
Xing, M., Wang, Y., Wang, X., Liu, J., Dai, W., Hu, G., He, F., Zhao, Q., Li, Y., Sun, L., Wang, Y., Du, S., Dong, Z., Pang, C., Hu, Z., Zhang, X., Xu, J., Cai, Q., & Zhou, D. (2023). Broad-spectrum vaccine via combined immunization routes triggers potent immunity to SARS-CoV-2 and its variants. Journal of Virology. https://doi.org/10.1128/jvi.00724-23
Vancouver
Xing M, Wang Y, Wang X, Liu J, Dai W, Hu G, et al. Broad-spectrum vaccine via combined immunization routes triggers potent immunity to SARS-CoV-2 and its variants. Journal of Virology. 2023. doi:10.1128/jvi.00724-23
BibTeX
@article{Xing2023,
author = {Xing, Man and Wang, Yihan and Wang, Xinyu and Liu, Jiaojiao and Dai, Weiqian and Hu, Gaowei and He, Furong and Zhao, Qian and Li, Ying and Sun, Lingjin and Wang, Yuyan and Du, Shujuan and Dong, Zhongwei and Pang, Chongjie and Hu, Zhidong and Zhang, Xiaoyan and Xu, Jianqing and Cai, Qiliang and Zhou, Dongming},
title = {Broad-spectrum vaccine via combined immunization routes triggers potent immunity to SARS-CoV-2 and its variants},
journal = {Journal of Virology},
year = {2023},
doi = {10.1128/jvi.00724-23}
}
EUVIMED